Is yearly intravenous zoledronic acid comparable to weekly oral alendronate for postmenopausal osteoporosis?

Affiliations

Comment

Maria Luisa Brandi. Nat Clin Pract Endocrinol Metab. 2008 Jan.

. 2008 Jan;4(1):20-1.

doi: 10.1038/ncpendmet0673.

¹ Department of Internal Medicine at the University of Florence, Florence, Italy. m.brandi@dmi.unifi.it

No abstract available

Comment on

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J. McClung M, et al. Bone. 2007 Jul;41(1):122-8. doi: 10.1016/j.bone.2007.03.011. Epub 2007 Mar 24. Bone. 2007. PMID: 17468062 Clinical Trial.